OR-RADISYS/TALLENCE
16.12.2020 14:02:11 CET | Business Wire | Press release
Radisys® Corporation , a global leader of open telecom solutions, today announced that Tallence AG , a digital transformation technology and management consultancy, has selected Radisys’ Engage Media Server as the foundation for a new voice messaging system for a Tier 1 European operator. Tallence will leverage the extensive capabilities of the Engage Media Server, a foundational element of the Radisys Engage communications services enablement platform, to create enhanced digital customer experiences with high quality interactions and augment content to create greater customer satisfaction and increase customer loyalty.
Highlights
- Digital communications solutions continue to become more integrated into both mobile and web paths of the customer journey. The COVID-19 pandemic is accelerating the shift in customer experience to online solutions. Application developers and Communication Service Providers (CSPs) must be able to quickly bring online new, scalable and elastic services that can be adapted to changing market conditions. With the right platform, they can meet the combined challenges of rapid increases and fluctuations in customer access traffic and increasingly remote, distributed workforces, all while enabling a top quality seamless experience.
- Traditionally, only large enterprises had the infrastructure and budgets to deliver compelling digital experiences that seamlessly tie voice and video interaction with content and business processes. By migrating these services to the cloud on the foundation of Radisys’ Engage Media Server, Tallence is providing services that enable businesses of all sizes to reach their consumers at lower cost, with greater flexibility, and optimal use of resources.
-
Radisys’ Engage Media Server delivers a rich set of media capabilities for developers and CSPs to create enhanced and engaging digital customer experiences. It provides the foundation for high-value voice and video features to enrich digital experience applications, and it enables CSPs to leverage the cloud for low cost and increased efficiency with industry-leading capacities for best total cost of ownership. The cloud-based Engage Media Server delivers:
- On demand scalability which reduces costs for broad market reach for digital experience applications and services at attractive price points.
- Optimal user experiences that tie to brand and customer satisfaction by using high quality voice and video, including real-time processing for 4G and 5G, PSTN, and web or mobile app modalities that can adapt to various bandwidth and network conditions and ensure CSPs can meet even the most rigorous availability and quality service level agreements with their customers.
- Powerful tools for application developers to quickly bring to market applications and services and on-demand adaptation for new campaigns through industry-leading analytics.
“Radisys’ Engage Media Server delivers the scalability and capabilities required for exceptional digital experience-related services for our new cloud-based voice messaging solution deployed for our tier-one customer,” said Christian Schöntag, Head of Consulting, Tallence AG. “Furthermore, Radisys’ extensive experience in cloud-based media processing is critical for enabling us to ensure reliability and scalability for our customers as they accelerate their move to the cloud.”
“Tallence AG has an impressive reputation in delivering innovative customer experiences that can provide compelling ROIs for their customers and sticky, loyalty building experiences for their end users,” said Al Balasco, Radisys’ Head of Media, Core and Applications Business. “Our Engage platform is deployed by over 150 operators and currently serves 2 billion users worldwide. Tallence’s cloud-based application builds on this mobile network-optimized platform to deliver services for a new age and represents the value of our media server to leading solution providers in enabling digital consumer experiences and e-commerce services.”
About Radisys
Radisys is a global leader in open telecom solutions and services. Its disaggregated platforms and integration services leverage open reference architectures and standards combined with open software and hardware, enabling service providers to drive open digital transformation. Radisys offers an end-to-end solutions portfolio from digital end points, to disaggregated and open access and core solutions, to immersive digital applications and engagement platforms. Its world-class and experienced network services organization delivers full lifecycle services to help service providers build and operate highly scalable and high-performance networks at optimum total cost of ownership. For more information, visit www.Radisys.com .
About Tallence
Tallence AG is a technology and management consultancy for digital transformation. We support our customers in using digitalization to their advantage and creating competitive advantages. We advise, develop and manage with a hands-on and result-oriented approach. Whether international technology group, traditional medium-sized enterprises or public sector: The benefit for the end customer is always the guiding principle and driving force behind Tallence. We ensure this through genuine expert performance and the highest level of commitment. Our clients come from diverse industries including telecommunications, information, media and energy. At Tallence AG more than 150 IT developers, machine learning specialists and management consultants based in our German office locations in Hamburg, Frankfurt, Marburg, Görlitz and Karlsruhe are working on future-oriented topics of the Digital Economy. Read more on: www.tallence.com .
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201216005062/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom